Dominic P. Behan
2016
In 2016, Dominic P. Behan earned a total compensation of $1.9M as Former Executive Vice President, Chief Scientific Officer and Director at Arena Pharmaceuticals, a 24% increase compared to previous year.
Compensation breakdown
| Option Awards | $525,998 |
|---|---|
| Salary | $306,046 |
| Other | $1,117,475 |
| Total | $1,949,519 |
Behan received $1.1M in other compensation, accounting for 57% of the total pay in 2016.
Behan also received $526K in option awards and $306K in salary.
Rankings
In 2016, Dominic P. Behan's compensation ranked 4,991st out of 14,075 executives tracked by ExecPay. In other words, Behan earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,991 out of 14,075 | 65th |
Division Manufacturing | 1,781 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 568 out of 1,895 | 70th |
Industry group Drugs | 424 out of 1,538 | 72nd |
Industry Pharmaceutical Preparations | 339 out of 1,176 | 71st |
Source: SEC filing on April 28, 2017.
Behan's colleagues
We found six more compensation records of executives who worked with Dominic P. Behan at Arena Pharmaceuticals in 2016.
2016
Amit Munshi
Arena Pharmaceuticals
Chief Executive Officer
2016
Steven Spector
Arena Pharmaceuticals
General Counsel
2016
Kevin Lind
Arena Pharmaceuticals
Chief Financial Officer
2016
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2016
Vincent Aurentz
Arena Pharmaceuticals
Executive Vice President and Chief Business Officer
2016
Harry Hixson
Arena Pharmaceuticals